<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">02725</article-id><article-id pub-id-type="doi">10.7554/eLife.02725</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>Mismatch repair deficiency endows tumors with a unique mutation signature and sensitivity to DNA double-strand breaks</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-12352"><name><surname>Zhao</surname><given-names>Hui</given-names></name><aff><institution>VIB Vesalius Research Center, KU Leuven</institution>, <addr-line><named-content content-type="city">Leuven</named-content></addr-line>, <country>Belgium</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-12398"><name><surname>Thienpont</surname><given-names>Bernard</given-names></name><aff><institution>VIB Vesalius Research Center, KU Leuven</institution>, <addr-line><named-content content-type="city">Leuven</named-content></addr-line>, <country>Belgium</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-12399"><name><surname>Yesilyurt</surname><given-names>Betül T</given-names></name><aff><institution>VIB Vesalius Research Center, KU Leuven</institution>, <addr-line><named-content content-type="city">Leuven</named-content></addr-line>, <country>Belgium</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-12400"><name><surname>Moisse</surname><given-names>Matthieu</given-names></name><aff><institution>VIB Vesalius Research Center, KU Leuven</institution>, <addr-line><named-content content-type="city">Leuven</named-content></addr-line>, <country>Belgium</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-12653"><name><surname>Reumers</surname><given-names>Joke</given-names></name><aff><institution>VIB Vesalius Research Center, KU Leuven</institution>, <addr-line><named-content content-type="city">Leuven</named-content></addr-line>, <country>Belgium</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-12401"><name><surname>Coenegrachts</surname><given-names>Lieve</given-names></name><aff><addr-line><named-content content-type="department">Division of Gynaecologic Oncology, Department of Obstetrics and Gynaecology</named-content></addr-line>, <institution>University Hospital Gasthuisberg</institution>, <addr-line><named-content content-type="city">Leuven</named-content></addr-line>, <country>Belgium</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-12405"><name><surname>Sagaert</surname><given-names>Xavier</given-names></name><aff><addr-line><named-content content-type="department">Division of Pathology</named-content></addr-line>, <institution>University Hospital Gasthuisberg</institution>, <addr-line><named-content content-type="city">Leuven</named-content></addr-line>, <country>Belgium</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-12406"><name><surname>Schrauwen</surname><given-names>Stefanie</given-names></name><aff><addr-line><named-content content-type="department">Division of Gynaecologic Oncology, Department of Obstetrics and Gynaecology</named-content></addr-line>, <institution>University Hospital Gasthuisberg</institution>, <addr-line><named-content content-type="city">Leuven</named-content></addr-line>, <country>Belgium</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-12407"><name><surname>Smeets</surname><given-names>Dominiek</given-names></name><aff><institution>VIB Vesalius Research Center, KU Leuven</institution>, <addr-line><named-content content-type="city">Leuven</named-content></addr-line>, <country>Belgium</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-12409"><name><surname>Matthijs</surname><given-names>Gert</given-names></name><aff><addr-line><named-content content-type="department">Department of Human Genetics</named-content></addr-line>, <institution>KU Leuven</institution>, <addr-line><named-content content-type="city">Leuven</named-content></addr-line>, <country>Belgium</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-3436"><name><surname>Aerts</surname><given-names>Stein</given-names></name><aff><addr-line><named-content content-type="department">Department of Human Genetics</named-content></addr-line>, <institution>University of Leuven</institution>, <addr-line><named-content content-type="city">Leuven</named-content></addr-line>, <country>Belgium</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-12410"><name><surname>Cools</surname><given-names>Jan</given-names></name><aff><addr-line><named-content content-type="department">Department of Human Genetics</named-content></addr-line>, <institution>KU Leuven</institution>, <addr-line><named-content content-type="city">Leuven</named-content></addr-line>, <country>Belgium</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-12411"><name><surname>Metcalf</surname><given-names>Alex</given-names></name><aff><addr-line><named-content content-type="department">Division of Genetics and Computational Biology</named-content></addr-line>, <institution>Queensland Institute of Medical Research</institution>, <addr-line><named-content content-type="city">Brisbane</named-content></addr-line>, <country>Australia</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-12412"><name><surname>Spurdle</surname><given-names>Amanda</given-names></name><aff><addr-line><named-content content-type="department">Division of Genetics and Computational Biology</named-content></addr-line>, <institution>Queensland Institute of Medical Research</institution>, <addr-line><named-content content-type="city">Brisbane</named-content></addr-line>, <country>Australia</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><collab>ANECS</collab><aff><addr-line><named-content content-type="department">The Australian National Endometrial Cancer Study</named-content></addr-line>, <institution>PO Royal Brisbane Hospital</institution>, <addr-line><named-content content-type="city">Brisbane</named-content></addr-line>, <country>Australia</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-12414"><name><surname>Amant</surname><given-names>Frederic</given-names></name><aff><addr-line><named-content content-type="department">Division of Gynaecologic Oncology, Department of Obstetrics and Gynaecology</named-content></addr-line>, <institution>University Hospital Gasthuisberg</institution>, <addr-line><named-content content-type="city">Leuven</named-content></addr-line>, <country>Belgium</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-11338"><name><surname>Lambrechts</surname><given-names>Diether</given-names></name><aff><institution>VIB Vesalius Research Center, KU Leuven</institution>, <addr-line><named-content content-type="city">Leuven</named-content></addr-line>, <country>Belgium</country><email>diether.lambrechts@vib-kuleuven.be</email></aff><xref ref-type="fn" rid="conf2"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1186"><name><surname>Stamatoyannopoulos</surname><given-names>John</given-names></name><role>Reviewing editor</role><aff><institution>University of Washington</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>01</day><month>08</month><year>2014</year></pub-date><volume>3</volume><elocation-id>e02725</elocation-id><supplementary-material><ext-link xlink:href="elife-02725-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>08</day><month>03</month><year>2014</year></date><date date-type="accepted"><day>30</day><month>07</month><year>2014</year></date></history><permissions><copyright-statement>Copyright © 2014, Zhao et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Zhao et al</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>DNA replication errors that persist as mismatch mutations make up the molecular fingerprint of mismatch repair (MMR)-deficient tumors and convey them with resistance to standard therapy. Using whole-genome and -exome sequencing, we here confirm an MMR-deficient mutation signature that is distinct from other tumor genomes, but surprisingly similar to germ-line DNA, confirming that a substantial fraction of human genetic variation arises through mutations escaping MMR. Moreover, we identify a large set of recurrent indels that may serve to detect microsatellite instability (MSI). Indeed, using endometrial tumors with immunohistochemically-proven MMR deficiency, we optimize a novel marker set capable of detecting MSI and show it to have greater specificity and selectivity than standard MSI tests. Additionally, we show that recurrent indels are enriched for the 'DNA double-strand break repair by homologous recombination' pathway. Consequently, DSB repair is reduced in MMR-deficient tumors, triggering a dose-dependent sensitivity of MMR-deficient tumor cultures to DSB inducers.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Diether Lambrechts, an inventor on a patent application regarding the use of recurrent indels to detect MSI. The VIB is owner of this patent application, and the said patent application has been licensed to an outside company. Neither VIB nor any of the authors have equity stakes in the company. However, VIB stands to eventually receive royalties.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Informed consent and consent to publish was obtained from all patients. Ethical approval was obtained at the ethical committee of University Hospital Gasthuisberg of Leuven with identifier ML2266.</p></fn></fn-group></back></article>